Presence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort Study

BACKGROUND: Nevirapine extended-release (NVP-XR) taken once daily remains an effective antiretroviral agent for patients infected with HIV-1 strains that do not harbor resistance mutations. Presence of tablet remnants of NVP XR in stools was reported in 1.19% and 3.05% of subjects in two clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yi-Chieh, Lin, Shu-Wen, Chen, Mao-Yuan, Chang, Sui-Yuan, Kuo, Ching-Hua, Sheng, Wang-Huei, Hsieh, Szu-Min, Sun, Hsin-Yun, Chang, Hsi-Yen, Wu, Mon-Ro, Liu, Wen-Chun, Wu, Pei-Ying, Yang, Shang-Ping, Zhang, Jun-Yu, Su, Yi-Ching, Luo, Yi-Zhen, Hung, Chien-Ching, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605833/
https://www.ncbi.nlm.nih.gov/pubmed/26465325
http://dx.doi.org/10.1371/journal.pone.0140574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605833/
https://www.ncbi.nlm.nih.gov/pubmed/26465325
http://dx.doi.org/10.1371/journal.pone.0140574

Ejemplares similares